Here are five observations:
1. The market was worth $17.6 billion in 2016, and is anticipated to hit $30.3 billion by 2025.
2. The growing number of orthopedic condition cases, such as bone degeneration and osteoarthritis, and an increasing aging population are boosting the market.
3. The knee replacement segment leads the market, and will likely increase its market share through 2027.
4. North America and Europe lead the global joint reconstruction devices market.
5. Dominant players include Medtronic, Stryker, Aesculap, Zimmer Biomet, DePuy Synthes, Smith and Nephew, CONMED, DJO Global, NuVasive, Tornier, Corin Group, Exactech, United Orthopedic Corporation, Japan MDM, Globus Medical, Arthrex and CONMED.
More articles on devices:
60k spine surgeries completed with SpineGuard’s PediGuard, DSG devices: 4 notes
Barrow Neurological Institute & Aesculap to hold live neurosurgery course: 5 things to know
Spineology adds Richard Nigon to board of directors: 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
